Penny L Hubbard Cristinacce1,2, Damien J McHugh1,2, Matthew R Orton2,3, Arnold JV Benjamin2,4, Ross A Little1,2, James P. B. O'Connor1,2,3, and Maite Jauregui-Osoro2,5
1The University of Manchester, Manchester, United Kingdom, 2National Cancer Imaging Translational Accelerator (NCITA), CRUK, United Kingdom, 3Institute of Cancer Research, Sutton, United Kingdom, 4University of Cambridge, Cambridge, United Kingdom, 5Imperial College London, London, United Kingdom
1The University of Manchester, Manchester, United Kingdom, 2National Cancer Imaging Translational Accelerator (NCITA), CRUK, United Kingdom, 3Institute of Cancer Research, Sutton, United Kingdom, 4University of Cambridge, Cambridge, United Kingdom, 5Imperial College London, London, United Kingdom
National Cancer Imaging Translational Accelerator (NCITA) is developing an MRI Core Lab to facilitate the validation and standardisation of quality assured imaging biomarkers. See the results of a QA/QC survey of clinical research MR conducted at research institutions across the UK.
Figure 1. What MRI phantoms/test objects does your institution/centre have available?
